qPCR diagnostic platform business plan

Challenge A research group at a leading research-intensive university had developed a qPCR diagnostic/ prognostic platform for patient stratification in autoimmune diseases which they believed could...
Learn More

Identifying and screening equity options for a diagnostics company

Challenge: Our diagnostics consultants were asked to develop an ex-US business development strategy and identify sources of non-dilutive finance for a well-backed, venture capital-funded diagnostics...
Learn More

Assessing an ophthalmic market opportunity

Challenge A leading research institute developing novel approaches for the production of ophthalmic treatments wanted to conduct a market and competitive assessment of the current supplier base and...
Learn More

Market assessment & opportunity mapping for an antibody discovery platform

Challenge A European research institute wanted to assess the market potential for a novel antibody discovery and screening platform, to enable the development of a commercialization strategy and plan.
Learn More

Pricing opportunity for a prescription surgical product

Challenge A publicly traded specialty pharma company was considering acquiring a company developing a prescription product for use by surgeons. We were asked to conduct an assessment of the market...
Learn More

Business planning & Monte Carlo simulations for cancer immunotherapy start-up

Challenge An established cancer immunotherapy company needed help with a business plan and valuation for a new company to be setup in collaboration with a major US cancer center
Learn More

Creating an investment strategy in a BRIC territory

Challenge A major public/private investor in a BRIC territory needed help with an investment strategy for building a nationwide radiopharmaceutical infrastructure and capacity in its home country....
Learn More

Radiopharma R&D Strategy

Challenge A major nuclear physics research institute looking to build a capability in nuclear medicine needed support with its R&D plan. Alacrita was engaged to help craft a new R&D strategy.
Learn More

Mapping an oncology project opportunity to support fundraising

Challenge: The technology transfer function of a leading cancer research institute needed a development plan for a promising small molecule lead series against a novel anti-invasion/anti-metastasis...
Learn More

UK payer needs for new device reimbursement

Challenge: A US medical device company wanted to understand how UK payers would view their technology. They engaged Alacrita to find out.
Learn More

Fundraising support for an oncology start-up

Challenge:  After a seed investment, a startup biotech had built an IP portfolio in the field of glucosinolates, chemicals found in brassica vegetables, that are potent inducers of cytoprotective...
Learn More
Content not found